- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01652352
Experimental Evaluation of Wheelchair-Mounted Robotic Arms (HRI)
HRI: Maximizing Manipulation of Persons With Disabilities Using a Smart Wheelchair-Mounted Robotic System
Researchers from the University of South Florida's Rehabilitation Engineering program are looking for volunteers to participate in a research study for experimental evaluation of wheelchair-mounted robotic arms (WMRAs).
Participants will operate commercially available and developmental WMRAs in a physical test environment. The study will serve to identify desirable design features of WMRAs and input devices so that future production systems may further increase the quality of life of potential users.
The study will also promote both the justification of prescribing WMRAs to enhance quality of life through the proposed standard testing method, and awareness for the emerging assistive robotics industry.
Study Overview
Status
Conditions
Detailed Description
Individuals with injuries or conditions resulting in both upper and lower body disabilities who are power wheelchair-bound are of key interest.
The purpose of this study is to experimentally evaluate up to six wheelchair mounted robotic arms (WMRAs). The goal is to quantitatively compare each device. In order to compare each device, patients will be asked to operate one of up to six wheelchair mounted robotic arms at a time. With each WMRA, patients will be asked to perform a series of up to four activities of daily living. patients will be presented with a survey at the conclusion of each task test. The survey is designed to quantitatively rank each WMRA's performance. The time to complete each task with each arm will also be recorded.
Patients will be asked some questions such as age, occupation, disability and/or physical limitations, and wheelchair use.
Patients will be asked to disclose pertinent medical information to determine their level of mobility. Then the patients and the research team will know whether or not they should be in the study.
If they take part in this study, patients will be asked to use a series of devices to control each of the six WMRAs to complete the following tasks:
- Open cabinets of varying heights
- Open drawers of varying heights
- Operate mock sink fixtures
- Operate mock light switches
- Plug into and out of mock electrical outlets
- Open personnel door
- Move objects on a table top
- Move objects on a book shelf
- Move a cup from a table top to the participant's mouth
- Perform any of the previous tasks under additional cognitive load * Additional cognitive load may include but is not limited to carrying on a conversation while attempting to perform a given task
Patients will be asked to spend about four hours in this study, which will be completed in one session at the Rehabilitation Robotics and Prosthetics Testbed at the University of South Florida. Break and refreshment time will be available during setup and installation time for each of up to six WMRAs. It is anticipated that twenty people will take part in this study at USF.
Participants who take part in this study may find quality of life benefits as a result of becoming familiar with WMRA assistive devices. Participants may find using a WMRA helpful in performing activities of daily living, though participants will not be given any of the WMRAs for personal use. The research study is directed at comparing and contrasting commercially available and developmental WMRAs. The study will also help to increase awareness of WMRAs and possibly help develop an assistive manipulator industry in the United States.
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
Florida
-
Tampa, Florida, United States, 33620
- Rehabilitation Robotics and Prosthetics Testbed
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Candidates will be recruited from University of South Florida facilities and through channels of normal operation of the Center for Assistive and Rehabilitation Robotic Technologies laboratory, its group members, and students.
Included candidate sources are primary and specialist care facilities in the Tampa Bay area, affiliates of USF, CARRT, and the College of Engineering, contacts of said organizations, and the general community.
Description
Inclusion Criteria:
- Be between the ages of 18 and 60
- Have an injury or condition resulting in power wheelchair dependence
- Consent to disclose pertinent medical information for purposes of determining level of mobility
Possess physical dexterity and capacity to operate the following devices:
- 16 button numeric keypad - dimensions: 3inch by 3inch square
- Touch screen tablet PC - dimensions: 15inch (diagonal)
- SpaceNavigator 3D joystick - movements: push, pull, lift, press, twist
- Standard joystick - movements: push, pull
- Chin joystick - movements: push, pull
- Possess capacity to understand the objective of each task, including but not limited to turning on a light switch, opening a cabinet, moving a cup from a table top to the participant's mouth, and opening a door
- Demonstrate the ability to understand, or become familiar with the basic function of both the input device and WMRA
- Spend up to four (4) hours, at one time, in the laboratory located at:
Rehabilitation Robotics and Prosthetics Testbed (RRT) 13335 Laurel Drive Tampa, FL 33620
- Consent to having a test platform temporarily attached to the participant's wheelchair. The attachment will use soft nylon straps and in no way inflict damage to the participant's property
- Sign an informed consent form
Exclusion Criteria:
-
Study Plan
How is the study designed?
Design Details
- Observational Models: Case-Control
Cohorts and Interventions
Group / Cohort |
|---|
|
Individuals with Disability
Power wheelchair-bound individuals with conditions which affect upper and lower body mobility, strength, or dexterity.
Such conditions may include but are not limited to spinal cord injury, Multiple Sclerosis, Cerebral Palsy, or other conditions which affect overall mobility.
|
|
Able-Bodied Individuals
Those who possess no condition or injury resulting in loss of mobility.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Efficacy - Ease of Use
Time Frame: Efficacy in performing a given task with a given wheelchair- mounted robotic arm will be recorded after three (3) repetitions of the task have been completed. Testing should take no longer than 4 hours.
|
In order to quantitatively evaluate the efficacy of each of up to six WMRAs, a survey will be presented to the participant at the conclusion of the final testing trial of each task of interest.
The participant will be asked to rate the ease of performing the given task with the given WMRA and input device on a number ranking scale.
The survey should be completed at the conclusion of testing trials for each task (the participant will be asked to perform up to four individual tasks).
|
Efficacy in performing a given task with a given wheelchair- mounted robotic arm will be recorded after three (3) repetitions of the task have been completed. Testing should take no longer than 4 hours.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Time of Completion
Time Frame: Time of completion will be recorded after each testing trial. Testing should take no longer than 4 hours.
|
The participant will be asked to perform a given task three (3) times.
These will be testing trials where time of performance will be recorded.
The time of performance will begin when the participant initializes the task.
The time of performance will stop when the task has been completed.
At the end of each testing trial, the task must be reset
|
Time of completion will be recorded after each testing trial. Testing should take no longer than 4 hours.
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Rajiv Dubey, Ph.D., Major Professor
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
- Brain Diseases
- Central Nervous System Diseases
- Nervous System Diseases
- Immune System Diseases
- Demyelinating Autoimmune Diseases, CNS
- Autoimmune Diseases of the Nervous System
- Demyelinating Diseases
- Autoimmune Diseases
- Wounds and Injuries
- Brain Damage, Chronic
- Trauma, Nervous System
- Spinal Cord Diseases
- Multiple Sclerosis
- Cerebral Palsy
- Spinal Cord Injuries
Other Study ID Numbers
- 105880 (Other Identifier: GSK)
- 0713560 (Other Grant/Funding Number: National Science Foundation)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Multiple Sclerosis
-
University Hospital, Basel, SwitzerlandSwiss National Science FoundationRecruitingMultiple Sclerosis (MS) | Relapsing-remitting Multiple Sclerosis (RRMS) | Secondary-progressive Multiple Sclerosis (SPMS) | Primary Progressive Multiple Sclerosis (PPMS)Switzerland
-
University of California, Los AngelesUnknownRelapsing-remitting Multiple Sclerosis | Secondary-progressive Multiple Sclerosis | Primary-progressive Multiple SclerosisUnited States
-
BiogenCompletedMultiple Sclerosis | Relapsing-Remitting Multiple Sclerosis | Secondary Progressive Multiple Sclerosis | Multiple Sclerosis, Primary Progressive | Multiple Sclerosis, Remittent ProgressiveJapan
-
Cabaletta BioNot yet recruitingProgressive Multiple Sclerosis | Multiple Sclerosis | Multiple Sclerosis (Relapsing Remitting) | Relapsing Multiple Sclerosis (RMS) | Progressive Multiple Sclerosis (PMS) | Multiple Sclerosis (MS) - Relapsing-remitting | Multiple Sclerosis - Relapsing Remitting
-
The Cleveland ClinicUniversity Hospitals Cleveland Medical CenterCompletedRelapsing-Remitting Multiple Sclerosis | Secondary Progressive Multiple Sclerosis | Progressive Relapsing Multiple SclerosisUnited States
-
Icahn School of Medicine at Mount SinaiColumbia University; New York Stem Cell Foundation Research InstituteCompletedClinically Isolated Syndrome | Relapsing-Remitting Multiple Sclerosis | Primary Progressive Multiple Sclerosis | Secondary Progressive Multiple SclerosisUnited States
-
Rigshospitalet, DenmarkOdense University Hospital; Aarhus University Hospital; Hvidovre University Hospital and other collaboratorsActive, not recruitingRelapsing Remitting Multiple Sclerosis | Primary Progressive Multiple Sclerosis | Secondary Progressive Multiple SclerosisDenmark
-
Novartis PharmaceuticalsCompletedRelapsing-remitting Multiple Sclerosis | Active Secondary Progressive Multiple SclerosisJapan
-
Banc de Sang i TeixitsVall d'Hebron Research Institute (VHIR)CompletedRelapsing-Remitting Multiple Sclerosis | Secondary Progressive Multiple SclerosisSpain
-
BiogenElan PharmaceuticalsCompletedRelapsing-Remitting Multiple Sclerosis | Secondary Progressive Multiple SclerosisUnited States